Drug intelligence / Profile preview

omija berry extract

Development stage
Unknown
Lead developer
HL Science
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Omija berry extract, derived from the fruit of *Schisandra chinensis*, is a botanical extract widely used in traditional Asian medicine and modern nutraceuticals. It is characterized by its high content of dibenzocyclooctadiene lignans, such as schisandrin A, B, and C, which are responsible for its adaptogenic, hepatoprotective, and ergogenic properties. The extract is primarily developed for improving physical performance, reducing fatigue, and supporting liver function. In South Korea, specific standardized versions like HL-JO01 have been recognized by the Ministry of Food and Drug Safety (MFDS) for their ability to improve muscle strength and function in aging populations. Its mechanism involves the modulation of oxidative stress pathways through Nrf2 activation and the inhibition of pro-inflammatory cytokines via the NF-κB pathway.

Brand names
Omija-X
Other names
Schisandra chinensis extractWu Wei Zi extractFive-flavor fruit extractSchisandra extract
02

Targets

TYR (Tyrosinase)

Beyond the preview

Go deeper on omija berry extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on omija berry extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call